Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MTPH.L Stock Summary
In the News
MTPH.L Financial details
Company Rating
Neutral
Market Cap
31.2M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
20
Optionable
No
Shortable
Yes
Earnings
24 Apr 2023
P/E
0
Forward P/E
-
PEG
-
P/S
44.64
P/B
-
P/C
-
P/FCF
-4.39
Quick Ratio
1.49
Current Ratio
2.47
Debt / Equity
0.2
LT Debt / Equity
0.15
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-18.45%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-139%
ROE
-112%
ROC
-2.46%
Gross Margin
-631%
Oper. Margin
-1278%
Profit Margin
-1095%
Payout
-
Shs Outstand
173.35M
Shs Float
2.45M
-
-
-
-
Target Price
-
52W Range
0.0-317.8
52W High
-
52W Low
-
RSI
-
Rel Volume
35.33
Avg Volume
38.93K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.21896
-
-
Volatility
6.48%, 6.48%
Prev Close
-
Price
-
Change
-
MTPH.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.5 | 0.67 | 0.16 | 0.14 | 0 | |
Net income per share | -66.85 | -9.06 | -10.36 | -1.36 | 0 | |
Operating cash flow per share | -86.72 | -6.43 | -4.34 | -1.49 | 0 | |
Free cash flow per share | -88.29 | -6.75 | -4.44 | -1.57 | 0 | |
Cash per share | 15.11 | 10.84 | 3.52 | 2.5 | 0 | |
Book value per share | 109.12 | 19.39 | 3.14 | 2.6 | 0 | |
Tangible book value per share | 29.34 | 7.12 | 3.14 | 2.6 | 0 | |
Share holders equity per share | 109.12 | 19.39 | 3.14 | 2.6 | 0 | |
Interest debt per share | 11.86 | 6.13 | 0.14 | 0.2 | 0 | |
Market cap | 3.67M | 11.3M | 11.35M | 14.7M | 0 | |
Enterprise value | 2.58M | 6.45M | 4.07M | 5.41M | -2.21M | |
P/E ratio | -0.35 | -1.24 | -0.51 | -2.69 | 0 | |
Price to sales ratio | 1.89 | 16.76 | 33.1 | 25.43 | 0 | |
POCF ratio | -0.27 | -1.74 | -1.22 | -2.45 | 0 | |
PFCF ratio | -0.27 | -1.66 | -1.19 | -2.32 | 0 | |
P/B Ratio | 0.22 | 0.58 | 1.69 | 1.41 | 0 | |
PTB ratio | 0.22 | 0.58 | 1.69 | 1.41 | 0 | |
EV to sales | 1.33 | 9.57 | 11.86 | 9.36 | -3.16 | |
Enterprise value over EBITDA | -0.25 | -0.64 | -0.43 | -0.82 | 0.26 | |
EV to operating cash flow | -0.19 | -0.99 | -0.44 | -0.9 | 0.31 | |
EV to free cash flow | -0.19 | -0.95 | -0.43 | -0.85 | 0.31 | |
Earnings yield | -2.83 | -0.81 | -1.95 | -0.37 | 0 | |
Free cash flow yield | -3.73 | -0.6 | -0.84 | -0.43 | 0 | |
Debt to equity | 0.07 | 0.31 | 0.04 | 0.07 | 0.2 | |
Debt to assets | 0.06 | 0.2 | 0.03 | 0.06 | 0.11 | |
Net debt to EBITDA | 0.11 | 0.48 | 0.77 | 1.41 | 0.26 | |
Current ratio | 2.27 | 2.42 | 3.1 | 6.39 | 2.47 | |
Interest coverage | -20.13 | -116.68 | -677.65 | -159.05 | -168.53 | |
Income quality | 0.89 | 0.64 | 0.42 | 1.1 | 0.92 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 2.11 | 5.7 | 14.44 | 5.1 | 6.5 | |
Research and developement to revenue | 4.41 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.61 | 0.4 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | 0.05 | 0.02 | 0.05 | 0.01 | |
Capex to revenue | -0.13 | -0.47 | -0.61 | -0.55 | -0.09 | |
Capex to depreciation | -0.17 | -0.25 | -0.17 | -0.79 | -0.18 | |
Stock based compensation to revenue | -0.02 | -0.05 | -1.18 | 0.15 | 0.18 | |
Graham number | 405.13 | 62.88 | 27.04 | 8.9 | 0 | |
ROIC | -0.54 | -0.35 | -3.05 | -0.52 | -2.13 | |
Return on tangible assets | -1.28 | -0.49 | -2.26 | -0.42 | -1.39 | |
Graham Net | -7.59 | -0.41 | 2.08 | 1.89 | 0 | |
Working capital | 3.15M | 8.07M | 6.29M | 9.92M | 2.79M | |
Tangible asset value | 4.55M | 7.18M | 6.72M | 10.45M | 3.16M | |
Net current asset value | 2.1M | 2.4M | 6.18M | 9.3M | 2.33M | |
Invested capital | 0.07 | 0.31 | 0.04 | 0.07 | 0.2 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 1.28M | 2.39M | 2.86M | 1.16M | 1.27M | |
Average inventory | 470.5K | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 12.2 | 209.14 | 73.99 | 85.64 | 103.34 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 29.91 | 1.75 | 4.93 | 4.26 | 3.53 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.61 | -0.47 | -3.3 | -0.52 | -2.42 | |
Capex per share | -1.57 | -0.32 | -0.1 | -0.08 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -7.29M | -3.39M | -9.29M | -5.71M | -2.21M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.04 | 0.22 | 0.07 | 0.1 | 0.2 | |
Debt to assets | 0.03 | 0.1 | 0.06 | 0.07 | 0.11 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 3.1 | 1.83 | 6.39 | 5.28 | 2.47 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 6.29M | 3.19M | 9.92M | 7.04M | 2.79M | |
Tangible asset value | 6.72M | 3.75M | 10.45M | 7.49M | 3.16M | |
Net current asset value | 6.18M | 2.5M | 9.3M | 6.5M | 2.33M | |
Invested capital | 0.04 | 0.22 | 0.07 | 0.1 | 0.2 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
MTPH.L Frequently Asked Questions
What is Midatech Pharma plc stock symbol ?
Midatech Pharma plc is a GB stock and trading under the symbol MTPH.L
What is Midatech Pharma plc stock quote today ?
Midatech Pharma plc stock price is $- today.
Is Midatech Pharma plc stock public?
Yes, Midatech Pharma plc is a publicly traded company.